Pomalidomide-amido-PEG3-C2-NH2 structure
|
Common Name | Pomalidomide-amido-PEG3-C2-NH2 | ||
---|---|---|---|---|
CAS Number | 2328070-52-4 | Molecular Weight | 476.48 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H28N4O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Pomalidomide-amido-PEG3-C2-NH2Pomalidomide-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 22) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology[1]. |
Name | Pomalidomide-amido-PEG3-C2-NH2 |
---|
Description | Pomalidomide-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 22) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology[1]. |
---|---|
Related Catalog | |
Target |
Cereblon |
In Vitro | Pomalidomide-amido-PEG3-C2-NH2 (Compound 5b) can be used to synthesize BI-3663. BI-3663 (cereblon-based) degrades focal adhesion tyrosine kinase (PTK2) with a median DC50 of 30 nM to >80% across a panel of 11 human hepatocellular carcinoma (HCC) cell lines[1]. |
References |
Molecular Formula | C22H28N4O8 |
---|---|
Molecular Weight | 476.48 |
Hazard Codes | Xi |
---|